65
Growth Score
pts
Heat Score
-1 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
687759
Vulcan Biosciences commercializes a therapy for treating multiple sclerosis (MS), a debilitating disease of the central nervous system.
- Archie Cobbs: COO
- Michael Heaven: Chief Scientific Officer
About the Company
Vulcan Biosciences commercializes a therapy for treating multiple sclerosis (MS), a debilitating disease of the central nervous system. Using Vulcan Biosciences mass spectrometry platform for drug discovery, the company has discovered two patent-pending lead drug candidates with a strong efficacy signal that suppresses paralysis in the preclinical
mouse model of MS, and have novel mechanisms-of-action compared to pre-existing treatments.
The company is headquartered in Birmingham Alabama and has the appropriate personnel to develop its MS drugs optimally for FDA trials and obtain the financing required to complete this process.
